跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mag-I
首页
药物
Mag-I
Mag-I
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
EP 4357454 A3
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
CN
EP
US
9 件公开
US 10538573 B2
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
CN
US
2 件公开
CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN
EP 3915999 A1
申请人: UNIV BASEL
优先权: 2014
CN
EP
US
4 件公开
MAG expression promoters
US 2005090531 A1
申请人: KAWASAKI MASAKAZU
优先权: 1999
CN
US
3 件公开
Glycopeptide compound as well as preparation method and application thereof
CN 120535587 A
申请人: UNIV SHANDONG
优先权: 2024
CN
High-affinity antigen of autoimmune disease antibody as well as synthesis method and application of high-affinity antigen
CN 121824645 A
申请人: UNIV SHANDONG
优先权: 2025
CN
药物
反馈